IDXX EBITDA Growth
Idexx Laboratories · EBITDA Growth
IDXX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported15.39%period ending
IDXX TTM EBITDA YoY % (-8.42% → 15.39%)
Year-over-year change
High-resolution chart · PNG
IDXX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 15.3925% | |
| 20.5306% | |
| 18.3166% | |
| 15.5999% | |
| 14.9249% | |
| 3.9093% | |
| 4.6587% | |
| 4.9631% | |
| 4.6865% | |
| 18.748% | |
| 20.1589% | |
| 21.3423% | |
| 20.7517% | |
| 0.5616% | |
| -2.4357% | |
| -3.5717% | |
| -0.193% | |
| 15.9243% | |
| 30.9797% | |
| 41.6635% | |
| 40.6468% | |
| 36.9713% | |
| 23.4724% | |
| 12.6682% | |
| 11.5637% | |
| 10.0709% | |
| 11.6943% | |
| 14.3344% | |
| 13.1472% | |
| 14.1807% | |
| 14.8063% | |
| 15.3939% | |
| 15.3315% | |
| 15.3847% | |
| 16.0396% | |
| 17.7465% | |
| 19.772% | |
| 20.6535% | |
| 16.3671% | |
| 22.5894% | |
| 18.1724% | |
| 14.9444% | |
| 15.7271% | |
| -2.6725% | |
| -1.1169% | |
| -1.7069% | |
| -0.7338% | |
| 6.1093% | |
| 4.6931% | |
| 4.2516% | |
| 2.0106% | |
| 5.8947% | |
| 7.398% | |
| 8.1929% | |
| 10.7286% | |
| 9.6613% | |
| 9.7544% | |
| 14.9201% | |
| 14.2399% | |
| 14.8019% | |
| 14.0559% | |
| 9.1277% | |
| 10.729% | |
| 10.9693% | |
| 18.3957% | |
| 10.3923% | |
| 13.0597% | |
| 11.4504% | |
| 3.987% | |
| 36.6554% | |
| 35.4333% | |
| 44.231% | |
| 43.8307% | |
| 11.2019% | |
| 8.6264% | |
| 1.5305% | |
| 3.652% | |
| 14.2659% | |
| 11.8437% | |
| 18.7104% | |
| 16.6571% | |
| 7.3062% | |
| 7.3602% | |
| 8.5361% | |
| 12.3873% | |
| 22.8551% | |
| 33.2189% | |
| 18.5554% | |
| 11.8834% | |
| 5.0738% | |
| -1.7131% | |
| 3.9911% | |
| 16.5101% | |
| 30.4757% | |
| 17.4197% | |
| 18.4493% | |
| 2.5556% | |
| -13.3423% | |
| 1.2965% | |
| 2.1466% |